跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tarlonib 150 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tarlonib 150
Approved
STANDARD
Tarlonib 150
Sun Pharmaceutical Industries Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1c95b2bafce81898
Company
Sun Pharmaceutical Industries Ltd.
Type
Standard
Approval Details
Approval Id
1c95b2bafce81898
Drug Approval Philippines Name
Tarlonib 150
Product Name
Tarlonib 150
Registration Number
DRP-10865
Brand Name
Tarlonib 150
Generic Name
Erlotinib (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
150 mg
Manufacturer
Sun Pharmaceutical Industries Ltd.
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-ltd
Issuance Date
27 June 2024
Expiry Date
30 April 2026
Pharmacologic Category
Antineoplastic Agent (Protein Kinase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1c95b2bafce81898
Type
Standard
Back to Philippines FDA Approvals